ArticleAmerican journal of cancer research2020

The CDK6-c-Jun-Sp1-MMP-2 axis as a biomarker and therapeutic target for triple-negative breast cancer.

Chi-Wen Luo et al.PubMed ↗Full text ↗

No numbers read from the abstract.